J. H. RENWICK* Ophthalmological geneticists are already accustomed to being in the lead. Colour blindness was one of the first human conditions to be studied genetically, and the linkages of the colour blindness and haemophilia loci that were studied by Bell and Haldane (1937) were the first human linkages to be recognized. Congenital cataracts were among the first serious genetic conditions to be treated effectively and this possibility of therapy may well have been the stimulus for the great researches of Nettleship and Usher soon after the discovery of Mendel's genetic work. Professor Arnold Sorsby continued, in Britain, the fine tradition these men established, and it is fitting to discuss here, in his Festschrift, a more recent 'first' that his chosen field of endeavour can now claim and which owes a good deal to his help and encouragement. This is the assignment of the first disease locus to a specific autosome. The total nuclear cataract (Fig.) , afflicting a large pedigree well studied by Nettleship (1909) , has its locus, appropriately enough, on the first chromosome. Part of the evidence bears on the linkage of this cataract locus to the Duffy blood group locus, Fy, which was the first linkage to be found with computer assistance (Renwick and Lawler, 1963) . The same computer programme also found the linkage between Fy and the'locus', Unl, that uncoils the secondary constriction of chromosome 1. This linkage placed Fy and hence the total-nuclear-cataract locus on chromosome 1 (Donahue et al., 1968; Ying and Ives, 1968) .
Before discussing this new development further, it will be useful to consider the present outlook for linkage studies and to discuss certain problems of heterogeneity that arise. Race and Sanger (1968) and in Giblett (1969) , including the addendum.
Cell hybridization techniques have recently opened exciting possibilities of mapping autosomal loci for which the phenotype can be scored in cell cultures (Migeon and Miller, 1968) . Unfortunately, few eye conditions can yet be scored in culture, and these methods will not be discussed here. (Franqois, I96I) by kind permission of Professor Jules Franqois. existence of such phenotypic mimicry by genotypes at two loci can be clear when one locus is on the X chromosome as proved to be the case in the mucopolysaccharidoses (gargoylism, etc.). Here it was only after this chromosomal heterogeneity of locus had been noticed that the clinical and biochemical delineation of the subtypes was undertaken. It was then appreciated that the X-borne (Hunter) allele (type II) usuaUy produces no corneal opacities even in male hemizygotes, whereas the autosomal allele responsible in the homozygote for the type I form of the disease often does lead to corneal opacities.
Problem of Classification
From the point of view of research strategy in linkage work, this potential heterogeneity of locus puts a large premium on the choosing of those loci for which the heterozygous phenotype is distinguishable from homozygous phenotypes either directly (as the disease itself) or indirectly through some laboratory procedure. Such a strategy potentially allows a large number of offspring of heterozygotes in a single pedigree to be scored as recombinant or non-recombinant with respect to a marker locus. A clear-cut linkage of the relevant locus in that pedigree alone might therefore be established. Addition of another pedigree involves some risk that it might dilute the clear indications of linkage by adding data on a different locus producing a mimic disease condition. Unfortunately, even pedigrees of heterozygous conditions are often not large enough to stand alone in a linkage search, and full use has then to be made of the clinical phenotypes as criteria for a preliminary pooling of data from unrelated pedigrees.
Heterogeneity of locus is thus a ubiquitous difficulty in linkage work. But it is also a stimulus: the resolution of the heterogeneity (at a fundamental level) that can result from a linkage study constitutes, in itself, a valuable advance.
The difficulty and the stimulus are both well illustrated for the congenital cataracts. Reference has already been made to the assignment of the total-nuclear-cataract locus, Cae, to chromosome 1. The probability that Cae is linked to Fy is now 0-96, and the probability that Fy is on chromosome 1 is 0-98. The latter figure takes into account unpublished data of M. A. Ferguson-Smith, M. M. Izatt, and J. H. Renwick; M. Bobrow and R. A. Sanger; as well as earlier pedigrees (see Donahue et al., 1968; Ying and Ives, 1968; Jacobs et al., 1970) .
It so happens that there is a slight hint that Fy may be linked also to the locus, Caf, of a more restricted cataract (a nuclear cataract). On one set of plausible prior probabilities, the probability that Lewontin (1965) , and other population geneticists, who have shown that there are evolutionary forces that tend to preserve such groupings and even build up others containing loci that interact in selection. This interaction has to be such that the selective advantage of genotypes in conjunction is not merely the product of the selective advantages of the genotypes at the various loci individually (Arunachalam, 1970 In short, genotypic diagnosis in man is usually incomplete, and linkage studies have a part to play in remedying this incompleteness. Such genotypic diagnosis has more than academic importance. In some of the early cataracts, for example, we are perhaps sampling alleles at some of the loci that are also concerned with senile cataracts. As soon as geneticists can arm themselves with knowledge of the linkage relationships of some of the loci for these early cataracts (that are relatively simple to study), they may begin to find it rewarding to study the cataract loci in pedigrees in which presenile cataract is common. And Vogt (1931) or Waardenburg, Franceschetti, and Klein (1961) ; and by reproductions from direct photography or slit-lamp microphotography (whatever its limitations) as well as by verbal description of intrafamilial variation, and by tabulations of rate of progression (if any) and of age of onset.
Neither the clinical approaches alone nor the linkage findings alone are likely to reveal the number of loci and the range of phenotypes that each locus, through its series of genotypes, accounts for. Both approaches will be required and, because there is no lack of promising leads for several linkages involving cataract loci, the time seems ripe for this concerted attack on the genetical and clinical classification of this group of conditions. The mapping of some locus untroubled by mimics would be easier, but the mapping of cataract loci, by potentially contributing to a resolution of the cataract classification problem, might well be more rewarding. Finally and rather importantly, if suitable linkages can be found with markers testable on the amniotic cells or fluid, the first steps in fundamental control of early genetic cataracts can be made by enabling parents to choose termination of a high-risk pregnancy (Edwards, 1956) . Summary An outline is given of some of the methods, the progress, and the prospects of mapping the loci of ophthalmic conditions on the human autosomes. The recent first assignment of a disease locusthat for total nuclear cataract-to a specific autosome (chromosome 1) is among the topics discussed. More general points are made about the variety of cataract loci that must be anticipated and about the possibility that these loci might be clustered on particular chromosomes.
